Inclusion Criteria:

- Signed informed consent before any trial related activity

- Proven prostate cancer with a need for endocrine treatment

- Testosterone level within the normal range for the age

Exclusion Criteria:

- Previous or current hormonal treatment of prostate cancer

- Candidate for prostatectomy or radiotherapy

- History of severe asthma, anaphylactic reactions or Quincke's Oedema

- Hypersensitivity towards any component of FE200486

- Cancer disease within the last ten years except for prostate cancer and some skin
cancers

- Presenting with significant neurological, gastrointestinal, renal, hepatic,
cardiovascular, psychological, pulmonary, metabolic, endocrine, haematological,
dermatological or infectious disorder. In addition any other condition such as
excessive alcohol or drug abuse that may interfere with trial participation or
influence the conclusion of the trial as judged by the investigator

- Mental incapacity or language barrier

- Having received an investigational product within the last 12 weeks preceding the
trial

- Previous participation in this trial